Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00639730 · ClinicalTrials.gov registry record · Phase 1

Use of the Atkins Diet for Children With Sturge Weber Syndrome

A Phase 1 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
5
Enrollment target

NCT00639730: Completed Phase 1 study, sponsored by Johns Hopkins University.

NCT00639730 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00639730, a Phase 1 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
5 participants
Enrollment target

Study Summary

This research is being done to find out if the Atkins Diet can be used safely and effectively to reduce seizures in children who have Sturge Weber syndrome. The ketogenic diet is a proven therapy for epilepsy, but can be difficult to use in children. The Atkins Diet is a high fat, high protein, low carbohydrate diet introduced in the 1970s to help with weight loss. It is different from the ketogenic diet in four major ways: no calorie restriction, no fluid restriction, no protein restriction, and is easy to start outside the hospital. People on the Atkins Diet become ketotic (produce high levels of ketones, a certain substance in the body), like patients on the ketogenic diet, and the investigators believe this may lead to seizure control. Children aged 2-18 with Sturge Weber syndrome and seizures at least monthly, who have used at least two anti-seizure drugs may join. 5 children in total will be enrolled.

Interventions

  • DIETARY_SUPPLEMENT modified Atkins diet

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2006-05
Est. Completion 2010-05
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00639730

The ClinicalTrials.gov registry entry for NCT00639730 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which modified Atkins diet is the first listed.

NCT00639730 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00639730 about?

NCT00639730 is a clinical study titled "Use of the Atkins Diet for Children With Sturge Weber Syndrome". This research is being done to find out if the Atkins Diet can be used safely and effectively to reduce seizures in children who have Sturge Weber syndrome. The ketogenic diet is a proven therapy for epilepsy, but can be difficult to use in children. The Atkins Diet is a high fat, high protein, low...

What is the current status of trial NCT00639730?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2006-05. Estimated completion is 2010-05.

What interventions are being tested in trial NCT00639730?

The interventions under investigation include: modified Atkins diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00639730?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.